Mechanistically, the phosphorylation of EGFR can stimulate several downstream signaling pathways, including MAPK/MEK/ERK and PI3K/AKT, that are involved in a variety of mitogenic, metastatic, and other tumor-promoting cellular activities (Wells, 1999; Roberts and Der, 2007). This evidence concerns the gene EGFR and neoplasm.